Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate InterCure Ltd. before investing.

In this article, we go over a few key elements for understanding InterCure Ltd.’s stock price such as:

• InterCure Ltd.’s current stock price and volume
• Why InterCure Ltd.’s stock price changed recently
• Upgrades and downgrades for INCR from analysts
• INCR’s stock price momentum as measured by its relative strength

About InterCure Ltd. (INCR)

Before we jump into InterCure Ltd.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Want to learn more about InterCure Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about InterCure Ltd..

InterCure Ltd.’s Stock Price as of Market Close

As of July 31, 2026, 3:59 PM, CST, InterCure Ltd.’s stock price was $0.962.

InterCure Ltd. is up 1.41% from its previous closing price of $0.948.

During the last market session, InterCure Ltd.’s stock traded between $0.945 and $0.990. Currently, there are approximately 15.90 million shares outstanding for InterCure Ltd..

InterCure Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

InterCure Ltd. Stock Price History

InterCure Ltd.’s (INCR) price is currently down 12.56% so far this month.

During the month of July, InterCure Ltd.’s stock price has reached a high of $1.140 and a low of $0.871.

Over the last year, InterCure Ltd. has hit prices as high as $1.770 and as low as $0.680. Year to date, InterCure Ltd.’s stock is up 5.69%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused InterCure Ltd. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded InterCure Ltd.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate InterCure Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on InterCure Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

InterCure Ltd.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about InterCure Ltd. (INCR) by visiting AAII Stock Evaluator.

Relative Price Strength of InterCure Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, InterCure Ltd. has a weighted four-quarter relative price strength of -8.65%, which translates to a Momentum Score of 27 and is considered to be Weak.

Want to learn more about how InterCure Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

InterCure Ltd. Stock Price: Bottom Line

As of July 31, 2026, InterCure Ltd.’s stock price is $0.962, which is up 1.41% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like InterCure Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.